| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2009-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1b860050f79799ba42161a8de20012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0985c3db006970c2165f352508f448f1 |
| publicationDate |
2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012197228-A |
| titleOfInvention |
Hepatitis treatment or prevention |
| abstract |
An object of the present invention is to provide a novel therapeutic or preventive agent capable of effectively acting on hepatitis, particularly hepatitis caused by hepatocyte damage caused by CD8 positive T cells. A therapeutic or prophylactic agent for hepatitis containing an antibody against CCL20 or an active fragment thereof as an active ingredient. The administration of the antibody against CCL20 improved the survival rate and pathological findings in the animal model, and a prophylactic effect and a therapeutic effect on hepatitis were observed. [Selection] Figure 6 |
| priorityDate |
2009-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |